Suppr超能文献

人嗜T淋巴细胞病毒I型信使核糖核酸在成人T细胞白血病/淋巴瘤患者体内表达:一项原位杂交研究

HTLV-I messenger RNA is expressed in vivo in adult T-cell leukemia/lymphoma patients: an in situ hybridization study.

作者信息

Setoyama M, Fujiyoshi T, Mizoguchi S, Katahira Y, Yashiki S, Tara M, Kanzaki T, Sonoda S

机构信息

Department of Dermatology, Faculty of Medicine, Kagoshima University, Japan.

出版信息

Int J Cancer. 1994 Jun 1;57(5):760-4. doi: 10.1002/ijc.2910570525.

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a malignancy involving peripheral blood, lymph nodes, skin and other organs. Human T-cell leukemia virus type I (HTLV-I) is etiologically associated with ATLL but cannot be detected by conventional methods in fresh samples of peripheral blood and skin taken from ATLL. The aim of this study was to investigate the feasibility of an in situ hybridization technique for detection of HTLV-I mRNA in atypical lymphoid cells of peripheral blood and skin lesions of patients with ATLL. We detected variable amounts of HTLV-I tax mRNA in the nuclei and cytoplasm of these cells in fresh peripheral blood samples and skin lesions from ATLL patients, and also in asymptomatic HTLV-I infected donors to a lesser extent. Out of 10 patients with ATLL, 7 showed strong positive in situ hybridization whereas the other 3 were only weakly positive. However, in the last 3 cases, the reaction became strongly positive after cells had been cultured for 24 hr. Furthermore, all 3 asymptomatic HTLV-I-infected donors exhibited a weakly positive response in their apparently mature lymphoid cells.

摘要

成人T细胞白血病/淋巴瘤(ATLL)是一种累及外周血、淋巴结、皮肤和其他器官的恶性肿瘤。I型人类T细胞白血病病毒(HTLV-I)在病因上与ATLL相关,但在取自ATLL患者的外周血和皮肤新鲜样本中,用传统方法无法检测到。本研究的目的是探讨一种原位杂交技术在检测ATLL患者外周血非典型淋巴细胞和皮肤病变中HTLV-I mRNA的可行性。我们在ATLL患者的新鲜外周血样本和皮肤病变中,以及在无症状HTLV-I感染供者中,在这些细胞的细胞核和细胞质中检测到了不同量的HTLV-I tax mRNA,但后者的量较少。10例ATLL患者中,7例原位杂交呈强阳性,另外3例仅为弱阳性。然而,在最后3例中,细胞培养24小时后反应变为强阳性。此外,所有3例无症状HTLV-I感染供者的明显成熟淋巴细胞均呈弱阳性反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验